123 related articles for article (PubMed ID: 35075977)
1. Atomistic mechanism of leptin and leptin-receptor association.
López-Hidalgo M; Caro-Gómez LA; Romo-Rodríguez R; Herrera-Zuñiga LD; Anaya-Reyes M; Rosas-Trigueros JL; Benítez-Cardoza CG
J Biomol Struct Dyn; 2023 Apr; 41(6):2231-2248. PubMed ID: 35075977
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target.
Tutone M; Pantano L; Lauria A; Almerico AM
J Mol Model; 2014 May; 20(5):2247. PubMed ID: 24797089
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody.
Carpenter B; Hemsworth GR; Wu Z; Maamra M; Strasburger CJ; Ross RJ; Artymiuk PJ
Structure; 2012 Mar; 20(3):487-97. PubMed ID: 22405007
[TBL] [Abstract][Full Text] [Related]
4. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
[TBL] [Abstract][Full Text] [Related]
5. Leptin and the OB-receptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti- obesity lead compounds.
Tutone M; Lauria A; Almerico AM
Curr Pharm Des; 2014; 20(1):136-45. PubMed ID: 24180400
[TBL] [Abstract][Full Text] [Related]
6. Structural and mechanistic paradigm of leptin receptor activation revealed by complexes with wild-type and antagonist leptins.
Moharana K; Zabeau L; Peelman F; Ringler P; Stahlberg H; Tavernier J; Savvides SN
Structure; 2014 Jun; 22(6):866-77. PubMed ID: 24882746
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced architecture of the leptin receptor signaling complex.
Mancour LV; Daghestani HN; Dutta S; Westfield GH; Schilling J; Oleskie AN; Herbstman JF; Chou SZ; Skiniotis G
Mol Cell; 2012 Nov; 48(4):655-61. PubMed ID: 23063524
[TBL] [Abstract][Full Text] [Related]
8. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex.
Peelman F; Iserentant H; De Smet AS; Vandekerckhove J; Zabeau L; Tavernier J
J Biol Chem; 2006 Jun; 281(22):15496-504. PubMed ID: 16540470
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists.
Girdhar K; Dehury B; Kumar Singh M; Daniel VP; Choubey A; Dogra S; Kumar S; Mondal P
J Biomol Struct Dyn; 2019 Sep; 37(15):3976-3986. PubMed ID: 30296922
[TBL] [Abstract][Full Text] [Related]
10. In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases.
Munikumar M; Krishna VS; Reddy VS; Rajeswari B; Sriram D; Rao MV
J Mol Graph Model; 2018 Jun; 82():20-36. PubMed ID: 29649778
[TBL] [Abstract][Full Text] [Related]
11. Pierced Lasso Bundles are a new class of knot-like motifs.
Haglund E; Sulkowska JI; Noel JK; Lammert H; Onuchic JN; Jennings PA
PLoS Comput Biol; 2014 Jun; 10(6):e1003613. PubMed ID: 24945798
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
13. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
14.
Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
Rezvani S; Ebadi A; Razzaghi-Asl N
J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
[TBL] [Abstract][Full Text] [Related]
16. The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.
Otvos L; Vetter SW; Koladia M; Knappe D; Schmidt R; Ostorhazi E; Kovalszky I; Bionda N; Cudic P; Surmacz E; Wade JD; Hoffmann R
Amino Acids; 2014 Apr; 46(4):873-82. PubMed ID: 24366600
[TBL] [Abstract][Full Text] [Related]
17. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
SarathKumar B; Lakshmi BS
J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment.
Rahman MM; Saha T; Islam KJ; Suman RH; Biswas S; Rahat EU; Hossen MR; Islam R; Hossain MN; Mamun AA; Khan M; Ali MA; Halim MA
J Biomol Struct Dyn; 2021 Oct; 39(16):6231-6241. PubMed ID: 32692306
[TBL] [Abstract][Full Text] [Related]
19. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
20. Leptin-Activity Modulators and Their Potential Pharmaceutical Applications.
Greco M; De Santo M; Comandè A; Belsito EL; Andò S; Liguori A; Leggio A
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
